{"id":"https://openalex.org/W2571017289","doi":"https://doi.org/10.1080/14737167.2017.1276829","title":"Granulocyte colony-stimulating factors in the prevention of febrile neutropenia: review of cost-effectiveness models","display_name":"Granulocyte colony-stimulating factors in the prevention of febrile neutropenia: review of cost-effectiveness models","publication_year":2017,"publication_date":"2017-01-02","ids":{"openalex":"https://openalex.org/W2571017289","doi":"https://doi.org/10.1080/14737167.2017.1276829","mag":"2571017289","pmid":"https://pubmed.ncbi.nlm.nih.gov/28064553"},"language":"en","primary_location":{"id":"doi:10.1080/14737167.2017.1276829","doi":"https://doi.org/10.1080/14737167.2017.1276829","is_oa":false,"landing_page_url":"https://doi.org/10.1080/14737167.2017.1276829","pdf_url":null,"source":{"id":"https://openalex.org/S98544388","display_name":"Expert Review of Pharmacoeconomics & Outcomes Research","issn_l":"1473-7167","issn":["1473-7167","1744-8379"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Pharmacoeconomics & Outcomes Research","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041311712","display_name":"Kelly Fust","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124242","display_name":"Optum (United States)","ror":"https://ror.org/0370sjj75","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124242"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kelly Fust","raw_affiliation_strings":["Health Economics & Outcomes Research, Optum, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics & Outcomes Research, Optum, Boston, MA, USA","institution_ids":["https://openalex.org/I4210124242"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076341878","display_name":"Anju Parthan","orcid":"https://orcid.org/0000-0002-2357-9479","observed_orcids":["https://orcid.org/0000-0002-2357-9479"]},"institutions":[{"id":"https://openalex.org/I4210124242","display_name":"Optum (United States)","ror":"https://ror.org/0370sjj75","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124242"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anju Parthan","raw_affiliation_strings":["Health Economics & Outcomes Research, Optum, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics & Outcomes Research, Optum, Boston, MA, USA","institution_ids":["https://openalex.org/I4210124242"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054110969","display_name":"Michael Maschio","orcid":"https://orcid.org/0000-0002-6595-3019","observed_orcids":["https://orcid.org/0000-0002-6595-3019"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Maschio","raw_affiliation_strings":["Health Economics & Outcomes Research, Optum, Burlington, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics & Outcomes Research, Optum, Burlington, ON, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071226035","display_name":"Qing Gu","orcid":"https://orcid.org/0000-0002-4171-083X","observed_orcids":["https://orcid.org/0000-0002-4171-083X"]},"institutions":[{"id":"https://openalex.org/I4210124242","display_name":"Optum (United States)","ror":"https://ror.org/0370sjj75","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124242"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qing Gu","raw_affiliation_strings":["Health Economics & Outcomes Research, Optum, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics & Outcomes Research, Optum, Boston, MA, USA","institution_ids":["https://openalex.org/I4210124242"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100459403","display_name":"Xiaoyan Li","orcid":"https://orcid.org/0000-0003-1910-2464","observed_orcids":["https://orcid.org/0000-0003-1910-2464"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaoyan Li","raw_affiliation_strings":["Global Health Economics, Amgen Inc., Thousand Oaks, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Health Economics, Amgen Inc., Thousand Oaks, CA, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073060840","display_name":"Gary H. Lyman","orcid":"https://orcid.org/0000-0002-0823-8086","observed_orcids":["https://orcid.org/0000-0002-0823-8086"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary H. Lyman","raw_affiliation_strings":["Public Health Sciences Division and Clinical Research Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Public Health Sciences Division and Clinical Research Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112396374","display_name":"Spiros Tzivelekis","orcid":"https://orcid.org/0009-0000-1357-1396","observed_orcids":["https://orcid.org/0009-0000-1357-1396"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Spiros Tzivelekis","raw_affiliation_strings":["Global Health Economics, Amgen Inc., Thousand Oaks, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Health Economics, Amgen Inc., Thousand Oaks, CA, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031997572","display_name":"Guillermo Villa","orcid":"https://orcid.org/0000-0003-4484-8858","observed_orcids":["https://orcid.org/0000-0003-4484-8858"]},"institutions":[{"id":"https://openalex.org/I4210139000","display_name":"Amgen (Switzerland)","ror":"https://ror.org/045wjte67","country_code":"CH","type":"company","lineage":["https://openalex.org/I1320553840","https://openalex.org/I4210139000"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Guillermo Villa","raw_affiliation_strings":["Global Health Economics, Amgen (Europe) GmbH, Zug, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Health Economics, Amgen (Europe) GmbH, Zug, Switzerland","institution_ids":["https://openalex.org/I4210139000"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110212915","display_name":"Milton C. Weinstein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Milton C. Weinstein","raw_affiliation_strings":["Department of Health Policy and Management; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA","Department of Health Policy and Management"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Policy and Management; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Department of Health Policy and Management","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5041311712"],"corresponding_institution_ids":["https://openalex.org/I4210124242"],"apc_list":null,"apc_paid":null,"fwci":0.0961,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.10683254,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"17","issue":"1","first_page":"39","last_page":"52"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.972000002861023},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.9900000095367432},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.781000018119812},{"id":"https://openalex.org/keywords/myelosuppressive-chemotherapy","display_name":"myelosuppressive chemotherapy","score":0.8820000290870667},{"id":"https://openalex.org/keywords/cancer-chemotherapy","display_name":"cancer chemotherapy","score":0.7429999709129333},{"id":"https://openalex.org/keywords/chemotherapy-dose-reduction","display_name":"chemotherapy dose reduction","score":0.7170000076293945},{"id":"https://openalex.org/keywords/pharmacoeconomic-model","display_name":"pharmacoeconomic model","score":0.7509999871253967}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8007677793502808},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.7647033929824829},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.7221691608428955},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6541397571563721},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6007193922996521},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.585040271282196},{"id":"https://openalex.org/C2777983669","wikidata":"https://www.wikidata.org/wiki/Q223143","display_name":"Granulocyte","level":2,"score":0.5301417112350464},{"id":"https://openalex.org/C2777767877","wikidata":"https://www.wikidata.org/wiki/Q419327","display_name":"Granulocyte colony-stimulating factor","level":3,"score":0.5112075805664062},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49530091881752014},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4202566146850586}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011322","descriptor_name":"Primary Prevention","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D011322","descriptor_name":"Primary Prevention","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018803","descriptor_name":"Models, Economic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055502","descriptor_name":"Secondary Prevention","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D055502","descriptor_name":"Secondary Prevention","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D064147","descriptor_name":"Febrile Neutropenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D064147","descriptor_name":"Febrile Neutropenia","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D064147","descriptor_name":"Febrile Neutropenia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/14737167.2017.1276829","doi":"https://doi.org/10.1080/14737167.2017.1276829","is_oa":false,"landing_page_url":"https://doi.org/10.1080/14737167.2017.1276829","pdf_url":null,"source":{"id":"https://openalex.org/S98544388","display_name":"Expert Review of Pharmacoeconomics & Outcomes Research","issn_l":"1473-7167","issn":["1473-7167","1744-8379"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Pharmacoeconomics & Outcomes Research","raw_type":"journal-article"},{"id":"pmid:28064553","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28064553","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of pharmacoeconomics & outcomes research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9907000064849854}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":76,"referenced_works":["https://openalex.org/W47581107","https://openalex.org/W116519768","https://openalex.org/W194795933","https://openalex.org/W652352161","https://openalex.org/W1546909751","https://openalex.org/W1548925964","https://openalex.org/W1828514487","https://openalex.org/W1855441706","https://openalex.org/W1975745084","https://openalex.org/W1981040752","https://openalex.org/W1983905226","https://openalex.org/W1988290414","https://openalex.org/W1988709547","https://openalex.org/W1990248717","https://openalex.org/W1990829116","https://openalex.org/W1993608325","https://openalex.org/W1993941594","https://openalex.org/W2000828799","https://openalex.org/W2010793522","https://openalex.org/W2011028259","https://openalex.org/W2013754529","https://openalex.org/W2014382998","https://openalex.org/W2023291563","https://openalex.org/W2024933507","https://openalex.org/W2029630138","https://openalex.org/W2035811581","https://openalex.org/W2036067444","https://openalex.org/W2036450045","https://openalex.org/W2037882380","https://openalex.org/W2043790030","https://openalex.org/W2048687800","https://openalex.org/W2055543087","https://openalex.org/W2057365773","https://openalex.org/W2058294694","https://openalex.org/W2059070026","https://openalex.org/W2068489602","https://openalex.org/W2069191600","https://openalex.org/W2076143652","https://openalex.org/W2077781144","https://openalex.org/W2083336892","https://openalex.org/W2084119896","https://openalex.org/W2084474661","https://openalex.org/W2084931982","https://openalex.org/W2089340094","https://openalex.org/W2089660436","https://openalex.org/W2091338492","https://openalex.org/W2096288062","https://openalex.org/W2096334407","https://openalex.org/W2100082529","https://openalex.org/W2101364628","https://openalex.org/W2104755629","https://openalex.org/W2107577958","https://openalex.org/W2110534467","https://openalex.org/W2110645520","https://openalex.org/W2112653328","https://openalex.org/W2115170812","https://openalex.org/W2119879346","https://openalex.org/W2120388840","https://openalex.org/W2122658272","https://openalex.org/W2125955497","https://openalex.org/W2131278861","https://openalex.org/W2133120925","https://openalex.org/W2136300726","https://openalex.org/W2137717503","https://openalex.org/W2142195688","https://openalex.org/W2149285284","https://openalex.org/W2150883028","https://openalex.org/W2152792488","https://openalex.org/W2155817335","https://openalex.org/W2157799421","https://openalex.org/W2166647521","https://openalex.org/W2169403306","https://openalex.org/W2171438287","https://openalex.org/W2338983050","https://openalex.org/W2341557816","https://openalex.org/W2513382862"],"related_works":["https://openalex.org/W7124311607","https://openalex.org/W1964870221","https://openalex.org/W2076143652","https://openalex.org/W47581107","https://openalex.org/W2138642935","https://openalex.org/W2183595750","https://openalex.org/W2091640685","https://openalex.org/W2084931982","https://openalex.org/W2543322418","https://openalex.org/W170061936"],"abstract_inverted_index":{"INTRODUCTION:":[0],"We":[1],"reviewed":[2],"the":[3,6,18,57],"evolution":[4],"of":[5,12,23,40,52],"methods":[7],"used":[8,59],"in":[9,17,27,75],"cost-effectiveness":[10],"analyses":[11],"granulocyte":[13],"colony-stimulating":[14],"factors":[15],"(G-CSFs)":[16],"primary":[19],"and":[20,48,64,103,110],"secondary":[21],"prevention":[22],"febrile":[24],"neutropenia":[25],"(FN)":[26],"patients":[28],"receiving":[29],"myelosuppressive":[30,41],"cancer":[31],"chemotherapy.":[32],"Areas":[33],"covered:":[34],"FN":[35,53,66,97],"is":[36],"a":[37,61,100],"side":[38],"effect":[39],"chemotherapy":[42,62,70,92,107],"associated":[43],"with":[44],"significant":[45],"morbidity,":[46],"mortality,":[47],"costs.":[49],"The":[50],"risk":[51,98],"may":[54,68],"depend":[55],"on":[56,99],"drugs":[58],"within":[60],"regimen,":[63],"an":[65],"event":[67],"cause":[69],"dose":[71,108],"reductions":[72,109],"or":[73],"delays":[74],"subsequent":[76],"cycles.":[77],"Expert":[78],"commentary:":[79],"More":[80],"recent":[81],"pharmacoeconomic":[82],"models":[83],"have":[84],"reflected":[85],"these":[86],"clinical":[87],"observations":[88],"by":[89,104],"modeling":[90],"sequential":[91],"regimens":[93],"to":[94],"account":[95],"for":[96,106],"per-cycle":[101],"basis,":[102],"accounting":[105],"consequent":[111],"survival":[112],"losses.":[113]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-01-13T00:00:00"}